Patents held by the MIT-Harvard Broad Institute for the use of the gene-editing tool CRISPR-Cas9 have been upheld by a federal appeals court, potentially bringing to an end a battle between the institute and the University of California, Berkeley.

J.R. Simplot Company has executed a joint intellectual property licensing agreement with Corteva Agriscience and the Broad Institute of MIT and Harvard for foundational CRISPR-Cas9 and related gene editing tools.

WASHINGTON, Oct. 25, 2017 - Two organizations that control the licensing of much of the foundational CRISPR-Cas9 genome editing intellectual property for use in agriculture decided to work together to make these tools available non-exclusively, removing roadblocks to expanded use of this technology.